S. 483: Responsibility in Drug Advertising Act of 2025
A Senate bill (S.) in the 119th U.S. Congress.
Overview
| Congress | 119th U.S. Congress (2025–2026) |
|---|---|
| Type | Senate bill (S.) |
| Originating chamber | Senate |
| Introduced | 2025-02-06 |
| Sponsor | Sen. King, Angus S., Jr. [I-ME] |
| Policy area | Health |
| Cosponsors | 2 |
| Latest action | 2025-02-06 — Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
| Last updated | 2026-01-21 |
Summary
Official summary (Introduced in Senate, 2025-02-06):
Responsibility in Drug Advertising Act of 2025
This bill prohibits direct-to-consumer advertising of new drugs during the first three years following their approval by the Food and Drug Administration (FDA). Direct-to-consumer advertising includes advertising via social media.
Upon request from a drug’s sponsor, the FDA may waive the prohibition during the third year following a drug’s approval if it determines that the direct-to-consumer advertising of the drug would have an affirmative value to public health. Conversely, the FDA may prohibit such advertising beyond the three-year period following approval if it determines that the drug has significant adverse health effects based on post-approval studies, adverse event reports, and other appropriate resources.
The prohibition applies to new drugs approved beginning one year before the bill’s enactment.
Cosponsors (2)
| Name | Party / state |
|---|---|
| Tim Kaine | D VA (original cosponsor) 2025-02-06 |
| Peter Welch | D VT (original cosponsor) 2025-02-06 |
Full text & official record
The official bill text, section-by-section summary, amendments, committee reports, and the complete legislative timeline for S. 483 are published by Congress on congress.gov.
Frequently asked questions
What is S. 483?
S. 483 is a Senate bill (S.) introduced in the 119th U.S. Congress, originating in the Senate. Official title: Responsibility in Drug Advertising Act of 2025.
Where can I read the full bill text?
The full text, cosponsors, amendments, and legislative status for S. 483 are available on congress.gov.
Bill data: congress.gov API (official congressional records).